sjaglin

Platelets in vascular inflammation: fire-fighters or... : Current Opinion in Hematology e potential therapeutic implications of targeting platelet function in inflammatory vascular diseases. Recent findings Platelets are essential components in the processes of hemostasis and thrombos...

From teams at @inserm.fr
journals.lww.com/co-hematolog...

This fourth article in a seven part series presents the Core GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach to addressing risk of bias, publication bias, and rating up certainty
www.bmj.com/content/389/...

An image from an animation explaining Anaesthesia, showing the various stages from preparation to recovery, using the image of a calendar and cartoons of doctors and patients.

'Anaesthesia explained' is our new animation for patients that explains:

☑️ The different types of anaesthetic
☑️ What to expect when you have surgery
☑️ How you can prepare
☑️ Discharge and recovery

Watch and share 👉 ow.ly/PzZ650VREPp

Produced with @wearecognitive.bsky.social

We've just finished an incredibly powerful & passionate discussion on early identification & prevention of #KidneyDisease in Westminster. One of the most powerful things we heard this evening came from one of our patient speakers: "Prevention isn't better than cure. It is the ONLY way forward."

Chief pharmaceutical officer welcomes RPS royal college switch The Royal College of Pharmacy will lead to improved collaboration and governance in the sector, according to David Webb, chief pharmaceutical officer for England. During a keynote address at the…

David Webb, chief pharmaceutical officer for England, has welcomed upcoming #RPS plans to become Royal College of Pharmacy

#rpharms

buff.ly/hAjxfvT

⚠️ Joining forces with 10 other patients orgs to produce a new report: 'Connected Care: Transforming Care Coordination' Read here 👇 kidneycareuk.org/news-from-ki...

We believe that no patient should have to explain their chronic condition (like #KidneyDisease) every time they seek care.

💛 In this #MentalHealthAwarenessWeek, we want to remind everyone that we're here to support anyone living with #KidneyDisease in the UK.

We are here to help you support you. Find out more 👉 kidneycareuk.org/kidney-disea...

Fake nurse crackdown to boost public safety New measures to make it a criminal offence for people who are not qualified as a nurse to use the title and mislead the public.

Looks like “Nurse” will become a protected title.

DHSC made this announcement today which is International Nurses day.

www.gov.uk/government/n...

Find out more about our partnership with @NIHRresearch on their PCAF scheme! shorturl.at/akYZ9

Day 2: @cpcongress.bsky.social “Becoming a Designated Prescribing Practitioner” by @grahamstretch.pharmsky.app
Sharing training that has been provided by ProPharmace.
The benefits shared by past participants and Foundation Years expectation.
#CPCongress #PCPAevents #PharmSky

Day 2: @cpcongress.bsky.social
Practical solutions shared by @grahamstretch.pharmsky.app as a Super DPP.
Considerations for your training plan.
#PharmSky #CPCongress

🚨Last chance to share your cutting-edge science! Late-breakthrough abstract submission for #ISTH2025 is OPEN. Deadline: May 14.

This is your opportunity to present high-impact, late-breaking research on the world stage.

📖Read full guidelines and submit: www.isth2025.org/late-breakthrough

The incidence and risk of venous thromboembolism in patients with active malignancy and isolated superficial venous thrombosis: a systematic review and meta-analysis (the IROVAM–iSVT review) The management of cancer-associated isolated superficial venous thrombosis (iSVT) remains controversial as cancer patients are at higher risk of bleeding and venous thromboembolism (VTE).

The incidence and risk of venous thromboembolism in patients with active malignancy and isolated superficial venous thrombosis: a systematic review and meta-analysis (the IROVAM–iSVT review) - Journal of Thrombosis and Haemostasis www.jthjournal.org/article/S153...

Direct oral anticoagulant failure in patients with venous thromboembolism—why and what next? Management of recurrent thrombotic events in patients taking a direct oral anticoagulant can be challenging. In this review, we consider causes of so-called direct oral anticoagulant failure, from poo...

Direct oral anticoagulant failure in patients with venous thromboembolism—why and what next? - Journal of Thrombosis and Haemostasis www.jthjournal.org/article/S153...

Continuity of care and reducing risk during transitions of care Introduction The World Health Organization (WHO) defines transitions of care (ToC) as the various points where a patient moves to, or returns from, a particular physical location or makes contact…

In our latest learning article, #MichaelWilcock considers the evidence of interventions to reduce risk during transitions of care and explains best practice for pharmacy teams
#ukpharmacy #transferofcare

How AI is transforming drug discovery “We want to industrialise drug discovery,” says Imran Haque, senior vice president of AI and digital sciences at Recursion, a start-up founded in Salt Lake City, Utah, in 2013. The company’s vision…

*How AI is transforming drug discovery*

Here, #RachelBrazil looks at how pharmaceutical companies and start-ups are harnessing #AI to improve speed and reduce costs in the #drugdiscovery and development process

UK’s first safer drug consumption facility accessed more than 2,500 times in first four months, data show The UK’s first safer drug consumption facility (SDCF) in Glasgow has been accessed 2,691 times during the four months it has been open, according to data published by the Glasgow City Health and…

The UK’s first safer drug consumption facility in Glasgow has been accessed 2,691 times during the four months it has been open, according to data published by the Glasgow City Health and Social Partnership

#ukpharmacy #controlleddrugs

Always impressed with the ability to capture talks in this format.

Here's the national digital, data and technology talk from Rahul Singal from today's Clinical Pharmacy Congress

Not too late to register and view the amazing educational material on #clots #VTE #Thrombosis organised by the fabulous team at #ThrombosisUK
tuk-edu.vfairs.com#agenda
Full program attached (sessions recorded)

We are proud to announce a new professional liability insurance policy, exclusive to RPS members.

Find out more including policy coverage and exclusions: bit.ly/3RSjyqA

Infographics from Thrombosis UK charity

🩸Did you know? 1 in 20 people will have a blood clot at some time in their life and the risk increases with age. However, knowing the risks, signs and symptoms can save lives.

bit.ly/TUKpatientinfo
#Thrombosis #Thrombosissky #VTEsky
@bhwords.bsky.social

Toute ma jeunesse!

Actually another saying from Binic: if you can't see the top of the church's spire it means it's raining. If you do, it means it's going to rain. Hope you like it!

Any chance to get a link to high resolution infographic? 😊

Highlight

#Medsky🧪 #IDsky #Immunosky #pharmasky #publichealth The systemic antiplatelet agents and #anticoagulants for the prevention and treatment of #thrombosis are comprehensively reviewed . This study compared the structure-function effects of APAC with those of UFH in vitro,

📢 New research alert!

📝 Our study in #Thrombosis and #Haemostasis explores anticoagulant use in life-limiting diseases

➡️ most patients continued therapy until end-of-life with comparable risks of bleeding or clots after stopping.

Kudos to Eve Kempers!

🔗 10.1055/a-2524-5334 […]

NATA WEBINAR
Tues. 25 March - 18:00 CET

Clotting, bleeding and pregnancy: pay attention!

🩸#VTE in pregnancy: what a mess we are in! What do we do now? Beverley HUNT
🩸#Anaemia in pregnancy – ironing out the problem. Sue PAVORD

🔗https://nataonline.com/monthly-live-webinars/

@bhwords.bsky.social

YouTube video by Thrombosis UK Diagnosing DVT clinically – just as hard as ever!

Presentations from #LTC24 now available. With tragic cases of missed diagnosis hitting the headlines, @bhwords.bsky.social discusses evidence & aids help raise early suspicion & diagnosis of #bloodclots 'Diagnosing DVT clinically – just as hard as ever!' youtu.be/9qDM6PIg1LE?... via @YouTube

Royal Pharmaceutical Society Greener Pharmacy Toolkit: How pharmacy champions in community and hospital settings can help to combat climate change Thursday 29 May 2025 | 7pm - 8pm Online via Zoom

Following the recent launch of the RPS Greener Pharmacy Toolkit, join our webinar on Thursday 29 May to find out how you can introduce more sustainable practices: eu.eventscloud.com/ereg/newreg....

Use the toolkit: rpharms.com/greenerpharm...

Medicines shortages are putting increasing pressure on pharmacy teams and impacting patient care. Our recent report highlights key areas for action to strengthen the UK’s response.

More: rpharms.com/medicinesshortages